Vitrolife appoints Elin Frostehav CEO

• Vitrolife appoints Elin Frostehav president and CEO effective May 1, 2027, or earlier.
• Frostehav currently leads Getinge’s Acute Care Therapies business; she previously served as vice president of Critical Care from 2019 to 2022.
• Rickard Ericsson, senior vice president of innovation, becomes interim president and CEO November 1, 2026, succeeding Bronwyn Brophy O'Connor.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vitrolife AB published the original content used to generate this news brief on October 26, 2026, and is solely responsible for the information contained therein.